JSW Steel's Q2FY27 net profit rose 225.3 per cent to ₹5,279 crore on higher volumes and realisations, while its board approved fresh investments in steelmaking and mining projects
In the grey markets, shares of Mankind Pharma enjoyed a premium of Rs 90, which translated to a likely listing price of Rs 1,170 per share on the upper price band